Home / Recalls / Akron Pharma, Inc. / D-0454-2023

D-0454-2023 Class III Terminated

Recalled by Akron Pharma, Inc. — Fairfield, NJ

Recall Details

Product Type
Drugs
Report Date
March 15, 2023
Initiation Date
February 17, 2023
Termination Date
September 9, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,416 tubes

Product Description

DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 2206016, Exp. date 05/2024

Other recalls by Akron Pharma, Inc.

  • D-0196-2025 Class III — Acetaminophen Extra Strength 500 mg, 1000 Tablets per bottle, Akron Pharma, Manu (December 12, 2024)
  • D-0194-2025 Class III — Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, In (December 12, 2024)
  • D-0193-2025 Class III — Acetaminophen Extra Strength 500 mg, 100 Tablets per bottle, Akron Pharma, Inc., (December 12, 2024)
  • D-0195-2025 Class III — Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufacture (December 12, 2024)
  • D-0198-2025 Class III — Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured (December 12, 2024)
  • D-0197-2025 Class III — Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured f (December 12, 2024)
  • D-0199-2025 Class III — Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured (December 12, 2024)
  • D-0025-2025 Class II — OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxati (October 15, 2024)
  • D-1352-2022 Class III — Acetaminophen 325 mg tablets, packaged in a) 100-count bottle (NDC 71399-8024-0 (August 4, 2022)
  • D-1353-2022 Class III — Acetaminophen 500 mg tablet, Extra Strength, packaged in a) 100-count bottle (ND (August 4, 2022)